A new CRISPR-based approach for tuning gene expression up and down allowed identification of how other genes' expression responds to changes of transcription factors.
SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...
This approval represents a significant regulatory milestone, making Proliv™Rx the first and only at-home neuromodulation ...
A new breakthrough study from the Rotman Research Institute at Baycrest, University of Toronto (Motsenyat et al., Brain Stimulation 2025) shows that brief sessions of pulsed photobiomodulation (PBM) ...
The newly released 1.0 specifications are for the physical media dependent layer and transmission convergence layer ...
Discover LucidMe Pro, a smart AI-powered sleep mask that tracks brain-wave signals in real-time to understand dreams as they ...
Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral ...
As these systems evolve, I believe therapeutic ultrasound is poised to become medicine's next general-purpose platform.
M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback